Evidence map›Paper›PMID 41600982›Full record

ArticleVaccines2026

Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models.

Hajar Mohammadi Barzelighi, Zahra Naderi Saffar, Erfan Pakatchian, Mohammad Taqavian, Babak Javadimehr, Mansooreh Safaeian, Payam Abbaszadeh, Hasan Jalili

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hajar Mohammadi BarzelighiResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Zahra Naderi SaffarResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Erfan PakatchianResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Mohammad TaqavianResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Babak JavadimehrResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Mansooreh SafaeianResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Payam AbbaszadehResearch and Development Department, Biosunpharmed Company, Tehran 1436935359, Iran.
Hasan JaliliDepartment of Life Sciences, Faculty of New Sciences and Technologies, University of Tehran, Tehran 1417935840, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HPVimmunogenicityreproductive toxicitysingle-dose and repeated-dose toxicityvaccine safety

Identifiers

PMID41600982
PMCPMC12846435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.